Late occurring clinical deep vein thrombosis in joint-operated patients

被引:116
作者
Dahl, OE
Gudmundsen, TE
Haukeland, L
机构
[1] Ullevaal Univ Hosp, Dept Orthopaed, NO-0182 Oslo, Norway
[2] Ullevaal Univ Hosp, Res Forum, NO-0182 Oslo, Norway
[3] Buskerud Cent Hosp, Dept Radiol, Buskerud, Norway
[4] Buskerud Cent Hosp, Dept Orthopaed, Buskerud, Norway
来源
ACTA ORTHOPAEDICA SCANDINAVICA | 2000年 / 71卷 / 01期
关键词
D O I
10.1080/00016470052943883
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
In a prospective study of 4,840 patients, we determined the annual incidence of clinical deep vein thrombosis (DVT) in mobilized, discharged orthopedic-operated "high-risk" patients (hip replacement surgery, knee replacement surgery, nailed hip fracture) and assumed "low-risk" patients (diagnostic knee arthroscopy), In addition, the time from the operation to the time when the patients were readmitted with clinically suspected DVT and the distribution of radiologically-confirmed DVT were recorded. Thromboprophylaxis was routinely given for about 10 days to the high-risk groups during the hospital stay but not to patients undergoing knee arthroscopy. During 9 years, the annual incidence of DVT following major procedures was 2.1% (95% CI 1.6-2.6) vs. 0.6% (95% CI 0.2-1.1) after diagnostic knee arthroscopy, Symptoms appeared, on average, 27 (3-150) days after total hip replacement surgery, 36 (3-150) days after nailed hip fracture, 17 (6-30) days after total knee replacement and 1 (1-6) day after knee arthroscopy. In hip-operated patients, 50% of the DVT's were found in the proximal veins vs. 40% following knee arthroplasty.
引用
收藏
页码:47 / 50
页数:4
相关论文
共 27 条
  • [1] Alatri A, 1998, THROMB HAEMOSTASIS, V79, P234
  • [2] Andreassen G, 1997, Tidsskr Nor Laegeforen, V117, P2026
  • [3] Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement
    Bergqvist, D
    Benoni, G
    Bjorgell, O
    Fredin, H
    Hedlundh, U
    Nicolas, S
    Nilsson, P
    Nylander, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (10) : 696 - 700
  • [4] Commentary on thromboprophylaxis in hip replacement surgery
    Bulstrode, CJK
    [J]. ACTA ORTHOPAEDICA SCANDINAVICA, 1998, 69 (04): : 343 - 344
  • [5] CAMPLIJNG EA, 1993, REPORT NATL CONFIDEN
  • [6] Prevention of venous thromboembolism
    Clagett, GP
    Anderson, FA
    Geerts, W
    Heit, JA
    Knudson, M
    Lieberman, JR
    Merli, GJ
    Wheeler, HB
    [J]. CHEST, 1998, 114 (05) : 531S - 560S
  • [7] Screening for deep-venous thrombosis after hip and knee replacement without prophylaxis
    Clarke, MT
    Green, JS
    Harper, WM
    Gregg, PJ
    [J]. JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1997, 79B (05): : 787 - 791
  • [8] INCREASED ACTIVATION OF COAGULATION AND FORMATION OF LATE DEEP VENOUS THROMBOSIS FOLLOWING DISCONTINUATION OF THROMBOPROPHYLAXIS AFTER HIP-REPLACEMENT SURGERY
    DAHL, OE
    ASPELIN, T
    ARNESEN, H
    SELJEFLOT, I
    KIERULF, P
    RUYTER, R
    LYBERG, T
    [J]. THROMBOSIS RESEARCH, 1995, 80 (04) : 299 - 306
  • [9] Dahl OE, 1997, THROMB HAEMOSTASIS, V77, P26
  • [10] FIBRIN FORMATION AND PLATELET-AGGREGATION IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION - EFFECTS OF INTRAVENOUS AND SUBCUTANEOUS LOW-DOSE HEPARIN
    GALLINO, A
    HAEBERLI, A
    HESS, T
    MOMBELLI, G
    STRAUB, PW
    [J]. AMERICAN HEART JOURNAL, 1986, 112 (02) : 285 - 290